Hinge Health, Inc. (HNGE) Financial Analysis & Valuation | Quarter Chart
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was fou... more
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs it... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $9.00B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | Daniel A. Perez |
| IPO Date | 2025-05-22 | CAGR | 41.71% |
| Employees | 1,437 | Website | www.hingehealth.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.01% | Total Yield | 0.01% |
HNGE chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $9.01B | P/E | 59.64 | Forward P/E | 36.48 | PEG | — |
| P/S | 54853.24 | P/B | 116826.48 | P/CF | 138337.25 | P/FCF | 137478.54 |
| Sales | $720.06M | Sales 1Y | 49.76% | Sales 3Y | — | Sales 5Y | — |
| EPS | $1.87 | EPS 1Y | -123.5% | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | 16.74% | EPS QoQ | 29.27% | Sales QoQ Avg | 11.27% | EPS QoQ Avg | -435.2% |
| Gross Margin | 84.52% | Operating Margin | 13.01% | Profit Margin | 15.15% | ROCE | 27.08% |
| ROA | 13% | ROE | 30% | Altman Z Score | 11.16 | Piotroski Score | 6 |
| Current Ratio | 1.34 | Quick Ratio | 1.3 | Cash Ratio | 0.59 | Op. CF Ratio | 0.21 |
| Debt/Equity | 0.02 | Debt/Assets | 0.01 | Lt Debt/Equity | 0 | Lt Debt/Cap. | — |
| Intrst Cov. | — | Inventory Turnover | 6.65 | Asset Turnover | 0.87 | Receivables Turnover | 5.74 |
| Enterprise Value | $9.01B | P/E Ratio | 59.64 |
| Forward P/E | 36.48 | PEG Ratio | — |
| P/S Ratio | 54853.24 | P/B Ratio | 116826.48 |
| P/CF Ratio | 138337.25 | P/FCF Ratio | 137478.54 |
| EPS | $1.87 | EPS Growth 1Y | -123.5% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 49.76% | Gross Margin | 84.52% |
| Operating Margin | 13.01% | Profit Margin | 15.15% |
| ROE | 30% | ROA | 13% |
| ROCE | 27.08% | Current Ratio | 1.34 |
| Quick Ratio | 1.3 | Cash Ratio | 0.59 |
| Debt/Equity | 0.02 | Interest Coverage | — |
| Altman Z Score | 11.16 | Piotroski Score | 6 |
Hinge Health, Inc. (HNGE) valuation & financials
Hinge Health, Inc. (HNGE) has a market capitalization of $9.00B and trades at a price-to-earnings ratio of 59.6. It operates in the Healthcare sector (Medical - Healthcare Information Services).
Hinge Health, Inc.'s revenue grew +49.8% over the last year.
Hinge Health, Inc.'s next earnings report is scheduled for November 2, 2026 after market close (provider scheduled date); analysts estimate EPS of $0.60. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)